Catch Prostate Cancer Early
Get screened today
Bringing the Mobile Unit to Georgia
In partnership with Winship Cancer Institute of Emory University and the Arthur M. Blank Family Foundation, the state-of-the-art mobile unit will serve Georgia
Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit
Under the direction of Ash Tewari, MBBS, MCh, FRCS (Hon.), Dsc (Hon.), and made possible by a donation from Robert F. Smith, Founder, Chairman, and Chief Executive Officer of Vista Equity Partners, the Mount Sinai Robert F. Prostate Cancer Screening Unit brings state-of-the-art imaging equipment and specialized staff directly to the communities that need them most.
Through community outreach, the program aims to:
- Raise awareness about the disease and services being offered by the mobile unit
- Set up prostate screening appointments at high-risk neighborhoods across New York City
- Schedule follow-up visits for patients with urologists at the Mount Sinai Center of Excellence for Prostate Cancer
Eligibility
About one in eight men in the United States will develop prostate cancer at some point in their lives. In fact, prostate cancer is the second most common form of cancer in U.S. men, behind skin cancer. Catching prostate cancer early is the best way to keep you healthy. The American Urological Association recommends that all men above age 55, and all Black men above age 45, consult with their doctor to discuss the benefits of screening. With early detection, prostate cancer can be treated successfully.
If you are male and 45-79 years old, you can get a prostate screening session at this unit.
Screening and Tests Available on the Unit
- PSA Test (Prostate-Specific Antigen): The PSA test is a blood test that measures the amount of prostate-specific antigen protein in your blood. PSA is a protein produced by both cancerous and noncancerous tissue in the prostate. The PSA test is used primarily to screen for prostate cancer.
- ExactVu Micro-Ultrasound System: With micro-ultrasound technology, doctors are able to visualize areas of suspected cancer and estimate how aggressive the cancer will be. Micro-ultrasound helps physicians perform biopsies that are more accurate and prevents unnecessary biopsies by allowing for a complete visual assessment of the patient’s prostate.
- EchoNous Bladder Scanner: An ultrasound machine uses sound waves to scan a patient’s bladder volume. The amount of urine in the bladder is measured by this scanner.
- Genomics: For those who have been diagnosed with cancer, a genomic test checks for gene mutations that can predict how the cancer might act. A genomic test could help your doctor tell how fast-growing your cancer might be and how likely it is to spread. A family history of prostate cancer increases a man’s risk by 60 percent.
Should you need additional care, Mount Sinai’s Center of Excellence for Prostate Cancer specializes in personalizing the right treatment plan for you. After further testing, our experts might determine that just monitoring your condition is best. If you have more advanced or aggressive prostate cancer, our specialists are skilled in the latest and most effective treatment options, including precision radiation therapy, advanced immunotherapy, hormone therapy, and chemotherapy. If you need surgery, Mount Sinai specialists have deep experience in robotic techniques that reduce pain and scarring and speed up your recovery time.
Throughout your care, our Urology Department’s Holistic Medicine, Nutrition, and Preventive Health Services will help you adopt good lifestyle habits and ensure you’re receiving the comprehensive care you need to lead a healthy life.
Making Your Appointment
You can make an appointment by calling 646-531-8092 or walk in without an appointment at any one of our screening events.
By the Numbers
Meet the Team
Susan Marshall, MD
Assistant Professor
Department of Urology
Mani Menon, MD
Chief of Strategy and Innovation in the Department of Urology
Icahn School of Medicine at Mount Sinai
Avinash Reddy, MD
Associate Professor
Department of Urology
Vinayak Wagaskar, MBBS
Assistant Professor
Department of Urology
Gerald P. Hoke, MD, MPH
Associate Professor
Department of Urology
Norman H. Coleburn, MD
Instructor
Department of Urology
Kyrollis Attalla, MD
Assistant Clinical Professor
Department of Urology
Funding by Robert F. Smith
Funded by a generous $3.8 million donation from philanthropist Robert F. Smith, the Mount Sinai Robert F. Smith Mobile Prostate Screening Unit is dedicated to addressing prostate health disparities. Launched in 2022, the mobile unit has logged some 15,000 miles across more than 600 community screening events and sites, screening more than 10,000 people.
Learn more about Robert F. Smith.